The ‘number needed to treat’ with Levetiracetam (LEV): Comparison with the other new antiepileptic drugs (AEDs)

Seizure

Volumn 11, Issue , 2002, Pages 235-236

  Rijckevorsel, K Van ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PLACEBO; TIAGABINE; TOPIRAMATE; VIGABATRIN; ZONISAMIDE;

ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; FOCAL EPILEPSY; HUMAN; LETTER; META ANALYSIS; PRIORITY JOURNAL; SOMNOLENCE; VERTIGO;

EID: 0034933480     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2001.0497     Document Type: Article

References (8)

1. New antiepileptic drugs: A systematic review of their efficacy and tolerability
2. Lamotrigine versus other antiepileptic drugs: A star rating system is born
3. New antiepileptic drugs: Comparison of key clinical trials
4. Analysis based on number needed to treat shows differences between drugs studied
5. The value of the number-needed-to-treat method in antiepileptic drug trials
6. The number needed to treat: A clinically useful measure of treatment effect
7. OCBZ, add on for drug resistent partial epilepsy
8. ZNS, add on for drug resistent partial epilepsy